Vermont · 2025-2026 Regular Session · Bill

H 859: An act relating to psychedelic therapy and clinical drug development trials

Introduced Last action February 3, 2026: Read first time and referred to the Committee on Health Care

Plain-language summary

H 859 is a bill introduced in the Vermont House on February 3, 2026. According to its official title, it concerns: An act relating to psychedelic therapy and clinical drug development trials. Primary sponsor: Brian Cina (Democratic/Progressive), Conor Casey (Democratic), Troy Headrick (Independent), Bram Kleppner (Democratic), Kate Logan (Democratic), Jubilee McGill (Democratic). Most recent recorded action (February 3, 2026): Read first time and referred to the Committee on Health Care.

Sponsors

Primary sponsors: Brian Cina (Democratic/Progressive); Conor Casey (Democratic); Troy Headrick (Independent); Bram Kleppner (Democratic); and 2 more.